Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-479-1 | CAS number: 2781-00-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 2009-2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Compliant to GLP and testing guideline; adequate coherence between data, comments and conclusions
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Breeder: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: approximately 9 weeks old
- Weight at study initiation: 22.4 +/- 1.2 g
- Housing: housed individually in disposable crystal polystyrene cages (22.00 cm x 8.50 cm x 8.00 cm). Each cage contained autoclaved sawdust.
- Diet (e.g. ad libitum): conventional laboratory diet (SSNIFF R/M-H pelleted maintenance diet)
- Water (e.g. ad libitum): tap water filtered using a 0.22 micron filter
- Acclimation period: at least 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2°C
- Humidity (%): 30 to 70%
- Air changes (per hr): 12 cycles/hour
- Photoperiod (hrs dark / hrs light): 12 h/12 h (7:00 - 19:00)
IN-LIFE DATES: From 18 November 2009 to 30 November 2009 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 2.5, 5, 10, 25 and 50%
- No. of animals per dose:
- 4 animals.
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: soluble in the first recommended vehicle, acetone/olive oil (4/1, v/v). A solution was obtained at the maximum tested concentration of 50%, after 15 minutes stirring.
- Irritation: non-irritant, whatever the concentration
- Lymph node proliferation response: incorporation of tritiated methyl thymidine
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response: SI >= 3 with exclusion of excessive irritation
TREATMENT PREPARATION AND ADMINISTRATION:
On days 1, 2 and 3, a dose-volume of 25 µL of the control or dosage form preparations was applied to the dorsal surface of both ears, using an adjustable pipette fitted with a plastic tip. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- HCA at the concentration of 25%: a moderate increase in cellularity and a stimulation index exceeding the threshold value of 3 (SI = 3.62) were noted. The study was therefore considered valid.
- Parameter:
- SI
- Remarks on result:
- other: Group 2 - test item 2.5% : 0.38 Group 3 - test item 5% : 0.40 Group 4 - test item 10% : 0.78 Group 5 - test item 25% : 1.87 Group 6 - test item 50% : 1.38
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- Group 1 - vehicle : 1763.28 (DPM per group) and 220.41 (DPM per node) Group 2 - test item 2.5% : 678.37 (DPM per group) and 84.80 (DPM per node) Group 3 - test item 5% : 705.51 (DPM per group) and 88.19 (DPM per node) Group 4 - test item 10% : 1370.06 (DPM per group) and 171.26 (DPM per node) Group 5 - test item 25% : 3293.61 (DPM per group) and 411.70 (DPM per node) Group 6 - test item 50% : 2438.58 (DPM per group) and 304.82 (DPM per node)
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Under the experimental conditions of this study, the test item 1,3(4) bis(tert butylperoxyisopropyl)benzene (batch No. 307090713) did not induce delayed contact hypersensitivity in the murine Local Lymph Node Assay.
- Executive summary:
The potential of the test item, 1,3(4)-bis(tert-butylperoxyisopropyl)benzene, to induce delayed contact hypersensitivity using the murine Local Lymph Node Assay (LLNA) was evaluated. Evaluation of local irritation was also carried out in parallel.
This study was conducted in compliance with the principles of Good Laboratory Practice Regulations.
Methods
A preliminary test was first performed in order to define the concentrations of test item to be used in the main test.
In the main test, twenty-eight female CBA/J mice were allocated to seven groups:
. five treated groups of four animals receiving the test item 1,3(4)-bis(tert-butylperoxyisopropyl)benzene at the concentration of 2.5, 5, 10, 25 or 50% in a mixture acetone/olive oil (4/1, v/v) (AOO),
. one negative control group of four animals receiving the vehicle (AOO),
. one positivie control group of four animals receiving the reference item, alpha-hexylcinnamaldehyde (HCA), a moderate sensitizer, at the concentration of 25% in AOO.
During the induction phase, the test item, vehicle or reference item was applied over the ears (25 µL per ear) for 3 consecutive days (days 1, 2 and 3). After 2 days of resting, the proliferation of lymphocytes in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (day 6). The obtained values were used to calculate Stimulation Indices (SI).
The irritant potential of the test item was assessed in parallel by measurement of ear thickness on days 1, 2, 3 and 6.
Results
The test item was soluble in the first recommended vehicle, acetone/olive oil (4/1, v/v).
A solution was obtained at the maximum tested concentration of 50%, after 15 minutes stirring.
Consequently, the concentrations selected for the preliminary test were 5, 10, 25 and 50%.
Since the test item was non-irritant in the preiminary test, the highest concentration retained for the main test was the maximal practicable concentration (50%).
Systemic clinical signs and mortality
Neither mortality nor clinical signs were observed during the study.
Local irritation
Dryness of the skin was noted on day 6 in 3/4 and 2/4 females given 25 and 50%, respectively.
No notable increase in ear thickness was observed in the animals of the treated groups.
Proliferation assay
A significant lymphoproliferation was noted with the positive control group given HCA at 25%. The study was therefore considered valid.
No notable lymphoproliferation was noted at any tested concentration.
The results are presented in the following table:
Treatment
Concentration
(%)
Irritation level
Stimulation Index
(SI)
Test item
2.5
non-irritant
0.38
Test item
5
non-irritant
0.40
Test item
10
non-irritant
0.78
Test item
25
non-irritant
1.87
Test item
50
slightly irritant
1.38
HCA
25
-
3.62
Conclusion
Under the experimental conditions of this study, the test item 1,3(4)-bis(tert-butylperoxyisopropyl)benzene (batch No. 307090713) did not induce delayed contact hypersensitivity in the murine Local Lymph Node Assay.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
There is no data on 1, (3) 4-bis(tert-butylperoxyisopropyl)benzene. A read across approach is proposed with 1,4-bis(tert-butylperoxyisopropyl)benzene.
1,(3) 4-bis(tert-butylperoxyisopropyl)benzene did not induce delayed contact hypersensitivity in a well conducted murine Local Lymph Node Assay (LLNA) (Klimisch 1 study).
The test item was non-irritant in the preliminary test, therefore the highest concentration retained for the main test was the maximal practicable concentration (50%).Neither mortality nor clinical signs were observed during the study.Dryness of the skin was noted on day 6 in 3/4 and 2/4 females given 25 and 50%, respectively but no notable increase in ear thickness was observed in the animals of the treated groups.
No notable lymphoproliferation was noted at any tested concentration.
Migrated from Short description of key information:
From the read across with 1, (3) 4-bis(tert-butylperoxyisopropyl)benzene: 1,4 bis(tert butylperoxyisopropyl)benzene does not induce delayed contact hypersensitivity in the murine Local Lymph Node Assay.
Justification for selection of skin sensitisation endpoint:
Key study, Klimisch 1.
Justification for classification or non-classification
According to regulation (EC) 1272/2008 and according to the directive 67/548/EEC: 1,4-bis(tert-butylperoxyisopropyl)benzene is not classified for skin sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
